Intuitive Ventures Closes $150 Million Fund II
With $250 million in assets under management, the corporate venture firm’s global focus spans diagnostics, MedTech, therapies, and digital health
Read MoreWith $250 million in assets under management, the corporate venture firm’s global focus spans diagnostics, MedTech, therapies, and digital health
Read MoreVyrsa Technologies is a privately held medical technology company focused on a minimally invasive treatment option for patients suffering from chronic sacroiliac joint pain
Read Moreto Make the Unseen Seen in Orthopedic, Neuro, and Spine Surgery
Read Moreto achieve FDA 510(k) clearance of the Glean™ Urodynamics System
Read MoreSiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success
Read MoreInnovative investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation
Read Morefor precise and streamlined introduction of diagnostic and therapeutic devices into the vasculature
Read MoreFocus on Technologies to Detect Lung Cancer, the Leading Cause of Cancer Deaths
Read Morehelps detect and localize pneumothorax (PTX) – providing immediate notification and overlay for the presence or absence of PTX
Read MoreRoche announced the official launch of the cobas® 5800 System, a new molecular laboratory instrument, in China. The cobas 5800 System helps laboratories meet the challenges of increased
Read More